Drug-eluting coronary stents--promise and uncertainty.

Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation (2013) 2.47

Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis. J Am Coll Cardiol (2016) 1.41

Application of a temporal reasoning framework tool in analysis of medical device adverse events. AMIA Annu Symp Proc (2011) 1.05

The bridging function of clinical pharmacology. Eur J Clin Pharmacol (2007) 0.88

Platelet adenosine diphosphate receptor antagonists: ticlopidine to ticagrelor-a long continuing journey. Indian Heart J (2012) 0.75

Another view of personalized medicine: optimizing stent selection on the basis of predicted benefit in percutaneous coronary intervention. Trends Cardiovasc Med (2012) 0.75

Heterogeneous Intravascular Ultrasound Findings of Stent Thrombosis. Intern Med (2017) 0.75

Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent model. J Vet Sci (2011) 0.75

From basic biology to randomized clinical trial: the Beta Radiation for Arteriovenous Graft Outflow Stenosis (BRAVO II). Semin Dial (2012) 0.75

Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med (2007) 5.77

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med (2007) 5.37

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med (2007) 4.95

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med (2007) 3.84

A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med (2007) 2.91

Unanswered questions--drug-eluting stents and the risk of late thrombosis. N Engl J Med (2007) 1.70

Stent thrombosis redux--the FDA perspective. N Engl J Med (2007) 1.60

Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med (2004) 14.78

Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA (2004) 14.17

Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med (2007) 12.55

Letting the genome out of the bottle--will we get our wish? N Engl J Med (2008) 9.10

Clinical trial registration: a statement from the International Committee of Medical Journal Editors. CMAJ (2004) 8.52

Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet (2004) 7.18

Data Sharing. N Engl J Med (2016) 5.12

Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Ann Intern Med (2004) 5.06

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet (2004) 5.01

Financial associations of authors. N Engl J Med (2002) 4.85

Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8. N Engl J Med (2005) 4.48

Clinical trial registration--looking back and moving ahead. N Engl J Med (2007) 4.07

Sharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors. Ann Intern Med (2016) 3.95

Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science (2002) 3.91

Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol (2002) 3.66

Registry research and medical privacy. N Engl J Med (2004) 3.49

Is this clinical trial fully registered?--A statement from the International Committee of Medical Journal Editors. N Engl J Med (2005) 3.44

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2002. A 28-year-old woman with ocular inflammation, fever, and headache. N Engl J Med (2002) 3.31

Physicians and execution. N Engl J Med (2008) 3.30

SARS, the Internet, and the Journal. N Engl J Med (2003) 3.16

Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12

Sharing Clinical Trial Data--A Proposal from the International Committee of Medical Journal Editors. N Engl J Med (2016) 3.06

Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med (2002) 2.94

The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev (2006) 2.80

A sad day for science at the FDA. N Engl J Med (2005) 2.77

Prescriptions, privacy, and the First Amendment. N Engl J Med (2011) 2.75

Data Sharing and the Journal. N Engl J Med (2016) 2.74

Inappropriate advertising of dietary supplements. N Engl J Med (2003) 2.73

A patient with asthma seeks medical advice in 1828, 1928, and 2012. N Engl J Med (2012) 2.72

Controlling research trials. N Engl J Med (2003) 2.70

A pivotal medical-device case. N Engl J Med (2008) 2.69

Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med (2004) 2.62

The FDA, politics, and plan B. N Engl J Med (2004) 2.53

Mechanotransduction through growth-factor shedding into the extracellular space. Nature (2004) 2.48

Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med (2009) 2.46

Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med (2003) 2.39

A pragmatic view of the new cholesterol treatment guidelines. N Engl J Med (2013) 2.30

Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors. Lancet (2016) 2.25

Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med (2002) 2.24

Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet (2002) 2.23

Believe the data. N Engl J Med (2012) 2.20

Awake and informed. N Engl J Med (2004) 2.16

Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Lancet (2005) 2.15

Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol (2003) 2.14

Public access to biomedical research. N Engl J Med (2004) 2.12

Sharing individual patient data from clinical trials. N Engl J Med (2015) 2.09

Legislative myopia on stem cells. N Engl J Med (2003) 2.03

COX-2 inhibitors--a lesson in unexpected problems. N Engl J Med (2005) 2.01

Expression of concern reaffirmed. N Engl J Med (2006) 1.97

Clinical trial registration. BMJ (2007) 1.95

Trial registration report card. N Engl J Med (2005) 1.89

Risks of long-acting beta-agonists in achieving asthma control. N Engl J Med (2009) 1.89

Clinical trial registration: looking back and moving ahead. Croat Med J (2007) 1.89

Endothelial nitric oxide synthase variants in cystic fibrosis lung disease. Am J Respir Crit Care Med (2002) 1.87

The Medical Device Safety Act of 2009. N Engl J Med (2009) 1.81

Revisiting the commercial-academic interface. N Engl J Med (2015) 1.79

Bronchial epithelial compression regulates epidermal growth factor receptor family ligand expression in an autocrine manner. Am J Respir Cell Mol Biol (2005) 1.79

Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. CMAJ (2005) 1.78

Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. Am J Respir Crit Care Med (2002) 1.76

Clinical trial registration: looking back and moving ahead. Ann Intern Med (2007) 1.71

Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. JAMA (2005) 1.65

Salvation by registration. N Engl J Med (2007) 1.63

Don't mess with the DSMB. N Engl J Med (2010) 1.60

Informed consent and SUPPORT. N Engl J Med (2013) 1.59

Toward more uniform conflict disclosures--the updated ICMJE conflict of interest reporting form. N Engl J Med (2010) 1.52

Decisions at the end of life. N Engl J Med (2003) 1.51

Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine. Clin Pharmacol Ther (2004) 1.51

Severity of intraoperative tricuspid regurgitation predicts poor late survival following cardiac transplantation. Ann Thorac Surg (2004) 1.49

Physicians and the First Amendment. N Engl J Med (2008) 1.43

Sharing clinical trial data. BMJ (2016) 1.43

Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Ann Intern Med (2005) 1.42

Peer review in the balance. N Engl J Med (2008) 1.42

The FDA and tobacco regulation. N Engl J Med (2008) 1.42

The growth of hospitalists and the changing face of primary care. N Engl J Med (2009) 1.42

Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Arch Dermatol (2005) 1.41

[Clinical trial registration: a statement from the International Committee of Medical Journal Editors]. Tidsskr Nor Laegeforen (2004) 1.41

Bronchial epithelial compression regulates MAP kinase signaling and HB-EGF-like growth factor expression. Am J Physiol Lung Cell Mol Physiol (2002) 1.40

Embryonic stem-cell research--the case for federal funding. N Engl J Med (2004) 1.40

Choosing asthma step-up care. N Engl J Med (2010) 1.40